相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37
K. L. Seib et al.
INFECTION AND IMMUNITY (2009)
Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci
Gunnstein Norheim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants - A randomized controlled trial
Matthew D. Snape et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen
Jo Anne Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA
Annalisa Ciabattini et al.
VACCINE (2008)
Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures
Anne Jakel et al.
VACCINE (2008)
Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody
Jo Anne Welsch et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Lack of association between group B meningococcal disease and autoimmune disease
Michael Howitz et al.
CLINICAL INFECTIOUS DISEASES (2007)
Glitazones in the treatment of cardiovascular risk factors
Mohamed Amine Bouhlel et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis
Vincent E. Weynants et al.
INFECTION AND IMMUNITY (2007)
Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis group B isolates in a serum, bactericidal antibody assay
Jamie Findlow et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
A prospective study of the effectiveness of the New Zealand meningococcal B vaccine
Colleen Kelly et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function
Hannah S. W. Lee et al.
INFECTION AND IMMUNITY (2007)
Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines
Synne Sandbu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Functional and specific antibody responses in adult volunteers in new Zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines
E. Wedege et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitildis group B in England
Caroline Trotter et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: Implications for the development of a multicomponent group B vaccine
Peter T. Beernink et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Safety review:: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease
H. Nokleby et al.
VACCINE (2007)
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand
P. Oster et al.
VACCINE (2007)
New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months
Sharon Wong et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks
Muhamed-Kheir Taha et al.
VACCINE (2007)
Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
Germie P. J. M. van den Dobbelsteen et al.
VACCINE (2007)
Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults
Scott A. Halperin et al.
VACCINE (2007)
Immunogenicity and safety of three doses of a bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents
Dominique Boutriau et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies
Yanwen Li et al.
INFECTION AND IMMUNITY (2006)
Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis
Martin J. Callaghan et al.
INFECTION AND IMMUNITY (2006)
Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac
Jamie Findlow et al.
INFECTION AND IMMUNITY (2006)
A universal vaccine for serogroup B meningococcus
Marzia M. Giuliani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis
Duzhang Zhu et al.
VACCINE (2006)
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB
DR Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine
T Luijkx et al.
VACCINE (2006)
Safety and immunogenicity of New Zealand strain meningococcal serogroup BOMV vaccine in healthy adults: Beginning of epidemic control
V Thornton et al.
VACCINE (2006)
Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model
DZ Zhu et al.
INFECTION AND IMMUNITY (2005)
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870
VC Hou et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination
M Fisseha et al.
INFECTION AND IMMUNITY (2005)
Meningococcal surrogates of protection - serum bactericidal antibody activity
R Borrow et al.
VACCINE (2005)
The concept of tailor-made, protein-based, outer membrane vesicle vaccines against meningococcal disease
J Holst et al.
VACCINE (2005)
MeNZB™:: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
P Oster et al.
VACCINE (2005)
Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B
S Pillai et al.
VACCINE (2005)
Vaccine potential of the Neisseria meningitidis 2086 lipoprotein
LD Fletcher et al.
INFECTION AND IMMUNITY (2004)
Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers
J Bruge et al.
VACCINE (2004)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter et al.
LANCET (2004)
Mucosal vaccination against serogroup B meningococci:: Induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin
F Bowe et al.
INFECTION AND IMMUNITY (2004)
Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia
JS Plested et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine
CL Vermont et al.
INFECTION AND IMMUNITY (2003)
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870
V Masignani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay et al.
BRITISH MEDICAL JOURNAL (2003)
Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease
J Holst et al.
VACCINE (2003)
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity
JA Welsch et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form
TA Luijkx et al.
INFECTION AND IMMUNITY (2003)
Neisseria lactamica protects against experimental meningococcal infection
KJ Oliver et al.
INFECTION AND IMMUNITY (2002)
NadA, a novel vaccine candidate of Neisseria meningitidis
M Comanducci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine
RK Katial et al.
INFECTION AND IMMUNITY (2002)
Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4(+) T lymphocytes
IC Boulton et al.
NATURE IMMUNOLOGY (2002)
Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants
SL Morley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
E Miller et al.
VACCINE (2001)
Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry
JS Plested et al.
INFECTION AND IMMUNITY (2001)
Reverse vaccinology, a genome-based approach to vaccine development
R Rappuoli
VACCINE (2001)
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection
R Borrow et al.
INFECTION AND IMMUNITY (2001)
Immunogenicity and safety of monovalent P1.7h,4 meningococcal outer membrane vesicle vaccine in toddlers:: comparison of two vaccination schedules and two vaccine formulations
ED de Kleijn et al.
VACCINE (2000)
Candidate Neisseria meningitidis NspA vaccine
D Martin et al.
JOURNAL OF BIOTECHNOLOGY (2000)
Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B
JS Plested et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing
M Pizza et al.
SCIENCE (2000)
Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age
ED de Kleijn et al.
VACCINE (2000)
分享论文
